Barrington Research Cuts U.S. Physical Therapy (NYSE:USPH) Price Target to $98.00

U.S. Physical Therapy (NYSE:USPH - Get Free Report) had its target price lowered by stock analysts at Barrington Research from $108.00 to $98.00 in a research note issued on Friday,Benzinga reports. The brokerage currently has an "outperform" rating on the stock. Barrington Research's price target indicates a potential upside of 23.33% from the stock's previous close. Barrington Research also issued estimates for U.S. Physical Therapy's Q3 2025 earnings at $0.67 EPS and Q3 2026 earnings at $0.79 EPS.

Several other equities analysts have also weighed in on USPH. Citizens Jmp upgraded shares of U.S. Physical Therapy to a "strong-buy" rating in a research report on Monday, December 16th. JPMorgan Chase & Co. increased their target price on U.S. Physical Therapy from $117.00 to $120.00 and gave the company an "overweight" rating in a report on Tuesday, December 3rd. Bank of America upgraded U.S. Physical Therapy from a "neutral" rating to a "buy" rating and lifted their price target for the company from $100.00 to $115.00 in a report on Monday, December 16th. William Blair restated a "market perform" rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. Finally, JMP Securities initiated coverage on U.S. Physical Therapy in a report on Monday, December 16th. They issued an "outperform" rating and a $113.00 target price on the stock. One analyst has rated the stock with a sell rating, one has given a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $111.50.

Remove Ads

U.S. Physical Therapy Stock Performance

Shares of U.S. Physical Therapy stock traded down $0.18 during trading on Friday, hitting $79.46. 112,622 shares of the stock were exchanged, compared to its average volume of 101,686. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. U.S. Physical Therapy has a 12 month low of $76.18 and a 12 month high of $113.63. The stock's fifty day moving average is $87.99 and its 200 day moving average is $87.62. The stock has a market cap of $1.20 billion, a PE ratio of 84.53, a P/E/G ratio of 3.54 and a beta of 1.48.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share for the quarter, missing analysts' consensus estimates of $0.69 by ($0.04). U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The business had revenue of $180.45 million for the quarter, compared to the consensus estimate of $173.10 million. As a group, sell-side analysts anticipate that U.S. Physical Therapy will post 2.67 EPS for the current year.

Insider Activity

In related news, CFO Carey P. Hendrickson sold 516 shares of the company's stock in a transaction on Monday, December 9th. The shares were sold at an average price of $96.25, for a total value of $49,665.00. Following the completion of the sale, the chief financial officer now directly owns 20,469 shares in the company, valued at approximately $1,970,141.25. This represents a 2.46 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 1.70% of the stock is owned by corporate insiders.

Institutional Trading of U.S. Physical Therapy

Large investors have recently made changes to their positions in the stock. Point72 Asset Management L.P. acquired a new stake in U.S. Physical Therapy in the 4th quarter worth approximately $18,886,000. Bahl & Gaynor Inc. grew its position in shares of U.S. Physical Therapy by 135.4% in the fourth quarter. Bahl & Gaynor Inc. now owns 260,125 shares of the company's stock valued at $23,076,000 after purchasing an additional 149,622 shares during the last quarter. State Street Corp increased its position in U.S. Physical Therapy by 17.5% in the 3rd quarter. State Street Corp now owns 667,868 shares of the company's stock worth $56,522,000 after buying an additional 99,244 shares during the period. Copeland Capital Management LLC raised its stake in U.S. Physical Therapy by 9.5% during the 4th quarter. Copeland Capital Management LLC now owns 839,356 shares of the company's stock valued at $74,459,000 after purchasing an additional 72,715 shares during the last quarter. Finally, Raymond James Financial Inc. acquired a new position in shares of U.S. Physical Therapy during the fourth quarter valued at about $6,240,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.